US Edition
Historic $40 Million Gift to CU Anschutz Dept. of Ophthalmology will Fuel Research and New Therapies
- On June 3, 2025, an anonymous donor contributed $40 million to the Department of Ophthalmology at the University of Colorado’s Anschutz Medical Campus in Aurora, Colorado, to advance research and treatment of serious eye conditions.
- A former patient of the Sue Anschutz-Rodgers Eye Center has made a donation intended to speed up research focused on combating common age-related vision disorders such as glaucoma and macular degeneration.
- This historic $40 million gift will support cutting-edge technology, attract leading experts, and create a dedicated endowment to advance innovative and fundamental research, including AI-enhanced diagnostic methods, within the Department of Ophthalmology.
- CU Chancellor Donald M. Elliman highlighted that the donation creates a significant opportunity to advance research essential to patient care, while Chair Naresh Mandava noted that this support could profoundly impact the outcomes for individuals affected by these conditions.
- The gift will enable faster translation of technology from lab to patient at Colorado’s only academic eye center, implying improved vision care for the 115,000 patients it serves annually and beyond.
13 Articles
13 Articles
Aspen Daily News
Historic $40 Million Gift to CU Anschutz Dept. of Ophthalmology will Fuel Research and New Therapies
The anonymous gift to Colorado's only academic eye center will boost research into treating and curing the most serious eye diseases while investing in new technology and recruiting top talent
Anonymous $40 million gift received by University of Colorado Anschutz Medical Campus Ophthalmology Department
The gift will be used to treat and potentially cure eye diseases like macular degeneration and glaucoma, increase focus on basic science, and harness artificial intelligence to revolutionize vision care.
NRFC Invests $27 Million in PolyActiva to Combat Glaucoma
Posted: 10 June 2025 The National Reconstruction Fund Corporation (NRFC) committed $27 million to PolyActiva as part of its $40 million Series C round. PolyActiva, a Melbourne-based biotechnology company, was developing a potentially revolutionary eye implant technology to… The post NRFC Invests $27 Million in PolyActiva to Combat Glaucoma first appeared on BioMelbourne Network.
University of Colorado Anschutz Medical Campus Ophthalmology Department receives $40 million gift
The gift will be used to treat and potentially cure eye diseases like macular degeneration and glaucoma, increase focus on basic science, and harness artificial intelligence to revolutionize vision care.
Coverage Details
Bias Distribution
- 75% of the sources are Center
To view factuality data please Upgrade to Premium
